OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 06:27:27 2024-05-13 EDT | ||
| 1.53 EUR | +1.32% |
|
| Current month | -8.48% | ||
| 1 month | +45.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 1.53 | +1.32% | 0 |
| 24-05-10 | 1.51 | +2.72% | 0 |
| 24-05-09 | 1.47 | +4.26% | 0 |
| 24-05-08 | 1.41 | +5.22% | 0 |
| 24-05-07 | 1.34 | -4.29% | 0 |
Real-time BOERSE MUENCHEN
Last update May 13, 2024 at 06:27 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ4F7P |
| ISIN | DE000GQ4F7P1 |
| Date issued | 2023-09-05 |
| Strike | 122.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.16 € |
|---|---|
| Lowest since issue | 0.377 € |
| Spread | 0.05 € |
| Spread % | 3.18% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.4
USD
Average target price
146.7
USD
Spread / Average Target
+6.01%
- Stock Market
- Certificates
- Certificat